[1]
Gontijo, M.F. da M.S.V. et al. 2026. 28457 – EPIDEMIOLOGICAL AND CLINICOPATHOLOGICAL PARAMETERS ASSOCIATED WITH NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER DURING THE COVID-19 PANDEMIC. Mastology. 34, suppl.2 (Feb. 2026). DOI:https://doi.org/10.29289/259453942024V34S2037.